News

Apr 06, 2023

Chris Cummins, Family Medicine Physician, Discusses Joint Injections for Pain

Dr. Christopher Cummins of Oxford is a family medicine physician who provides

Dr. Christopher Cummins of Oxford is a family medicine physician who provides patients with various in-office procedures to assist in pain management. In the following article, Dr. Chris Cummins discusses the use of joint injections for osteoarthritis pain.

Millions of people suffer from osteoarthritis around the world, especially in joints like the knee. For these sufferers, relief can be found in the form of injection medication like the GenVisc 850, created by OrthogenRX.

According to OrthogenRX, those who suffer from joint pain can find relief in as few as 3 injections of their GenVisc 850 product, even though the product is approved for up to 5 injections. This product has been shown to relieve the pain of those with osteoarthritis even when analgesics and non-pharmacologic therapy has no effect.

Below, Chris Cummins, Family Medicine Physician, reviews the benefits of OrthogenRX's product, the GenVisc 850 injection of hyaluronic acid. These detailed benefits will show that the GenVisc 850 product is worthwhile for those who suffer from osteoarthritic pain.

Chris Cummins, M.D., explains that GenVisc 850 is proven to work, and is safe and effective for managing pain. Dr. Cummins dives into details to demonstrate how useful and worthwhile this product is, even to those who are apprehensive about injections but are in need of relief for their joint pain.

In any form of medical treatment, whether therapeutic or, as in this case, pharmacological, safety should be priority number one.

Chris Cummins, M.D., reports that OrthogenRX's GenVisc 850 is an entirely safe product. However, like any medical procedure, it may carry some side effects and risks. The most common side effects of this quick, in-office procedure include mild swelling and pain at the injection site.

Each syringe contains 10mg/mL of sodium hyaluronate dissolved in a physiological saline (1.0% solution). The sodium hyaluronate is derived from bacterial fermentation, and FDA approved.

Through careful trial and error, it has been demonstrated as a product that is safe for repeated injection cycles. This is proof that GenVisc 850 injections are quite safe for the vast majority of patients to relieve joint pain, especially for those who have not found relief with other methods such as medication or physical therapy.

Dr. Christopher Cummins of Oxford notes that sometimes, the safety of medical products cannot rely solely on ingredient lists or the claims of manufacturers. It demands concrete evidence and validation from diverse sources. Enter OrthogenRX and their breakthrough injection medication, GenVisc 850—a product that surpasses the standard of proof without a shred of uncertainty.

GenVisc 850 has been FDA approved for use in more than 60 countries. Additionally, more than 40 million syringes of the product have been distributed to offices around the globe.

Furthermore, it brings immense reassurance to discover that this products boasts the most extensive and comprehensive series of double-blind clinical trials focused on hyaluronic acids for knee osteoarthritis. With the longest duration and largest sample size, it surpasses other treatments in terms of evidence-based support. Dr. Christopher Cummins from Oxford affirms that GenVisc 850's robust validation extends even further, having been featured in over 30 studies conducted in reputable clinical settings.

Chris Cummins, Family Medicine Physician, says that GenVisc 850 not only lessens pain, but it relieves large amounts of that pain over significant periods of time. In fact, patients usually experience relief from pain for as many as 30 weeks after their first cycle of injections. Even on the WOMAC index, this product lowers stiffness, pain, and functional capacity for 30 weeks.

Chris Cummins, Family Medicine Physician, notes that injections can be incredibly helpful to those who are part of the millions that suffer from osteoarthritis. OrthogenRX's GenVisc850 injections have proven to be particularly effective when it comes to relieving pain in the joints. This can be seen in the numerous clinical studies that have lauded the product.

Additionally, the product is FDA approved a safe to use in repeated injection cycles.

Finally, out of the 45 million doses that have been administrated all over the world, those who have received GenVisc 850 injections have reported pain relief that is not only significant, but actually lasts for much longer than 30 weeks, on average. With such proven effectiveness and safety, those who suffer from joint pain should certainly consider GenVisc 850 injections.